oa South African Medical Journal - Oxprenolol slow-release with cyclopenthiazide-KCL compared with methyldopa in the treatment of essential hypertension - a multicentre general practice trial



Two hundred and thirty-eight patients with essential hypertension from 39 general practice centres were treated in 7 double-blind trial with either oxprenolol 160 mg in a slow-release (SR) formulation with cyclopenthiazide 0,25 mg and potassium chloride 600 mg given once daily, or methyldopa 250 mg 3 times daily.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error